Altasciences Clinical Kansas Inc.
Overland Park, KS Part of Kofile Technologies, Inc.
- UEI
- WZ5RGEMMQ3W9
- CAGE
- 6PS73
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Dallas, TX
GUUCEJ3BYEB4
-
Parent
Dallas, TX
GUUCEJ3BYEB4
- SAM.gov registration date
- Physical address
- 10103 Metcalf Ave, Overland Park, KS 66212, USA
- Website
- altasciences.com
- Founded
- 1992
- Employees
- 1K-5K
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $303,647 |
| FY2025 | $1,627,884 |
| FY2024 | $1,607,905 |
| FY2023 | $1,838,615 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $303,647 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| IT1 Source LLC | 75N93023F00001 | $217,585 |
Similar vendors
About the company
Altasciences Clinical Kansas Inc. is a for-profit contract research organization (CRO) located in Overland Park, Kansas, registered in SAM.gov since 2012. The company specializes in providing advanced clinical research services, particularly in the pharmaceutical and medical research domains, with a strong focus on substance use disorder (SUD) studies and pharmacological research. As a child entity within a larger corporate structure, Altasciences Clinical Kansas Inc. offers comprehensive clinical trial and pharmacological research services to federal agencies, demonstrating expertise in conducting complex medical investigations.
The company has been awarded multiple prime federal contract awards primarily from the National Institute on Drug Abuse (NIDA) and the Food and Drug Administration (FDA), focusing on specialized clinical trials and pharmacological research. These contracts include a $1,838,615 delivery order for Phase 1 cocaine drug interaction trials, a $1,436,776 contract for investigational agent safety and tolerability studies, and a $2,370,057 contract with the FDA for a dose-finding pilot study of kratom alkaloids. None of these contracts were set aside for small businesses, indicating Altasciences Clinical Kansas Inc. competes effectively in the open market. The company's work consistently involves detailed pharmacokinetic and pharmacodynamic trials, demonstrating deep expertise in medication development for substance use disorders.
Altasciences Clinical Kansas Inc. holds a significant single-award indefinite delivery contract (IDV) with NIDA valued at $21 million, which runs from September 25, 2023, to September 24, 2028. This IDV is specifically designed for pharmacokinetic and pharmacodynamic trials supporting medication development in substance use disorders. Under this contract vehicle, the company has already received multiple delivery orders, including trials to assess safety, tolerability, and pharmacokinetics of investigational agents. The IDV allows NIDA to issue task orders for advanced clinical research services, with Altasciences Clinical Kansas Inc. positioned as a key research partner in developing potential treatments for substance use disorders. The contract's broad scope enables the company to conduct various clinical trials and research studies that advance medical understanding and potential therapeutic interventions.
Quick answers
Is Altasciences Clinical Kansas Inc. registered in SAM.gov?
Yes. Altasciences Clinical Kansas Inc.'s SAM.gov registration is active through June 30, 2027.
How much has Altasciences Clinical Kansas Inc. received in federal contracts?
Federal contracts obligated $1,627,884 to Altasciences Clinical Kansas Inc. in fiscal year 2025 and $5,378,051 in fiscal years 2023 through 2027.
How does Altasciences Clinical Kansas Inc. rank among federal contractors?
Altasciences Clinical Kansas Inc. ranked #56 in PSC AN11 in FY2025.
What is Altasciences Clinical Kansas Inc.'s most recent federal award?
Altasciences Clinical Kansas Inc.'s most recent federal contract award is Investigational agent single ascending dose safety, tolerability, and PK study. POP: 5/2/2025 - 11/1/2026. N01DA-23-8935 (75N95025F00001), from National Institute on Drug Abuse (NIH), on May 2, 2025.
On GovTribe
See Altasciences Clinical Kansas Inc.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors